These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease. Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159 [TBL] [Abstract][Full Text] [Related]
24. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease. Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181 [No Abstract] [Full Text] [Related]
25. Effects of betamethasone on serum iodothyronines and thyroid hormone-binding proteins in Graves' disease. Gamstedt A; Järnerot G; Kågedal B; Tegler L Acta Med Scand; 1986; 220(3):237-40. PubMed ID: 3776699 [TBL] [Abstract][Full Text] [Related]
26. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880 [TBL] [Abstract][Full Text] [Related]
28. A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery? Al Jassim A; Wallace T; Bouhabel S; Majdan A; Hier M; Forest VI; Payne R J Otolaryngol Head Neck Surg; 2018 May; 47(1):37. PubMed ID: 29784035 [TBL] [Abstract][Full Text] [Related]
29. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy. Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177 [TBL] [Abstract][Full Text] [Related]
30. Thyroid function during pregnancy in women with past Graves' disease. Luton D; Le Gac I; Noel M; Guibourdenche J; Polak M BJOG; 2005 Nov; 112(11):1565-7. PubMed ID: 16225580 [TBL] [Abstract][Full Text] [Related]
31. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease. Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711 [TBL] [Abstract][Full Text] [Related]
32. Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months. Kiso Y; Yoshida K; Kaise K; Kaise N; Fukazawa H; Mori K; Abe K; Yoshinaga K J Clin Endocrinol Metab; 1991 Feb; 72(2):515-8. PubMed ID: 1899425 [TBL] [Abstract][Full Text] [Related]
33. Thyroxine toxicosis in patients with iodine induced thyrotoxicosis. Sobrinho LG; Limbert ES; Santos MA J Clin Endocrinol Metab; 1977 Jul; 45(1):25-9. PubMed ID: 577497 [TBL] [Abstract][Full Text] [Related]
34. Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen. Dahlberg PA; Karlsson FA; Lindström B; Wide L Clin Endocrinol (Oxf); 1981 Jun; 14(6):555-62. PubMed ID: 6895351 [TBL] [Abstract][Full Text] [Related]
35. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease. Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866 [TBL] [Abstract][Full Text] [Related]
36. Symptomatology of Graves' disease and Plummer's disease in relation to age and thyroid hormone level. Tak PP; Hermans J; Haak A Neth J Med; 1993 Jun; 42(5-6):157-62. PubMed ID: 8377872 [TBL] [Abstract][Full Text] [Related]
37. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease. Balázs C; Kiss E Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729 [TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases. Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968 [TBL] [Abstract][Full Text] [Related]
39. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism. Laurberg P J Clin Endocrinol Metab; 1987 May; 64(5):969-74. PubMed ID: 3558731 [TBL] [Abstract][Full Text] [Related]
40. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]